This morning Dexcom released preliminary fourth quarter results along with guidance for 2021. At first we couldn’t figure out why then we remembered that today marks the beginning of the J P Morgan Healthcare Conference which like every other conference is now a virtual event. The results as per Dexcom tradition came in just fine with the 2021 guidance disappointing also a Dexcom tradition. Naturally shares have been selling off in early trading which is creating an opportunity for smart investors to jump in or add to their holdings.
It almost seems silly that investors have yet to learn . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.